Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Trevi Therapeutics, Inc. (TRVI) had Weighted-Average Shares Outstanding (Diluted) of 145.59M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.19M |
|
-- |
|
-- |
|
$14.91M |
|
$-14.91M |
|
$1.70M |
|
$-13.21M |
|
$-13.21M |
|
$-13.19M |
|
$-13.19M |
|
$-13.19M |
|
$-13.19M |
|
$-14.91M |
|
$-14.88M |
|
145.59M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
145.59M |
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$176.12M |
|
$0.27M |
|
$3.48M |
|
$179.61M |
|
$7.12M |
|
-- |
|
$0.36M |
|
$7.48M |
|
$172.13M |
|
$172.13M |
|
$172.13M |
|
128.41M |
|
| Cash Flow Statement Financials | |
$-16.69M |
|
$16.96M |
|
$0.22M |
|
$18.91M |
|
$19.41M |
|
$0.50M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.66% |
|
-7.66% |
|
-7.34% |
|
-7.66% |
|
$1.34 |
|
$-0.12 |
|
$-0.11 |
|